Argenica Therapeutics Ltd (ASX: AGN) — Healthcare · Share Price, Chart & Market Data
About: Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.19 (-5.13%)
AGNArgenica Therapeutics Ltd
Loading watchlist status…
Trade AGN now
Argenica Therapeutics Ltd share price
AGN price activity
Last Price
Change (24hr)
AUD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
17 Apr, 10:53 pm GMT+0
AGN price performance
23,333%
5D
-7,5%
1M
-39,344%
YTD
-72,794%
1Y
AGN price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
ASX rank
N/A
Sector Rank
N/A
Delayed
17 Apr, 10:53 pm GMT+0
AGN details
AGN Market Signals